poster

A Competitive Ligand-binding Assay for the Detection of Neutralizing Antibodies Against XTMAB-16

Frontage develops a full validation of the XTMAB-16 NAb (neutralizing antibody) assay with acceptable drug and target tolerances to guide future clinical trials.

Register to gain access to gated resources.

"*" indicates required fields

Country
Please only hit the submit button once.
I AGREE*
This field is for validation purposes and should be left unchanged.